Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice

Microbiology and Immunology

Volumn 43, Issue 1, 1999, Pages 87-91

  Aosai, Fumie ^a   Mun, Hye Seong ^a   Norose, Kazumi ^a   Chen, Mei ^a   Hata, Hidekazu ^a   Kobayashi, Masashi ^a   Kiuchi, Masahiro ^a   Stauss, Hans J ^b   Yano, Akihiko ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Gene vaccine; Protective immunity; SAG1 transfectants; Toxoplasma gondii

Indexed keywords

PROTOZOAL VACCINE;

ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; IMMUNIZATION; MOUSE; NONHUMAN; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

EID: 0032924698     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb02378.x     Document Type: Article

References (32)

1. Aosai, F., Öhlen, C., Ljunggren, H.G., Höglund, P., Franksson, L., Ploegh, H.L., Townsend, A., Kärre, K., and Stauss, H.J. 1991. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur. J. Immunol. 21: 2767-2774.
2. Aosai, F., Yang, T.H., Ueda, M., and Yano, A. 1994. Isolation of naturally processed peptides from a Toxoplasma gondii-infected human B lymphoma cell line that are recognized by cytotoxic T lymphocytes. J. Parasitol. 80: 260-266.
3. +CTL. Jpn. J. Parasitol. 44: 210-217.
4. Bülow, R., and Boothroyd, J.C. 1991. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J. Immunol. 147: 3496-3500.
5. Burg, J.L., Perelman, D., Kasper, L.H., Ware, P.L., and Boothroyd, J.C. 1988. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 141: 3584-3591.
6. Buxton, D. 1990. Toxoplasmosis. Practitioner 234: 42-44.
7. Darcy, F., Maes, P., Gras-Masse, H., Auriault, C., Bossus, M., Deslee, D., Godard, I., Cesbron, M.F., Tartar, A., and Capron, A. 1992. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J. Immunol. 149: 3636-3641.
8. De Bruijn, M.L., Schumacher, T.N., Nieland, J.D., Ploegh, H.L., Kast, W.M., and Melief, C.J. 1991. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. Eur. J. Immunol. 21: 2963-2970.
9. Gallimore, A., Dumrese, T., Hengartner, H., Zinkernagel, R.M., and Rammensee, H.G. 1998. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J. Exp. Med. 187: 1647-1657.
10. Grant, I.H., Gold, J.W., Rosenblum, M., Niedzwiecki, D., and Armstrong, D. 1990. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 4: 519-521.
11. + Tcells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147: 2310-2316.
12. Kärre, K., Ljunggren, H.G., Piontek, G., and Kiessling, R. 1986. Selective rejection of H-2 deficient lymphoma variants suggests alternative immmune defense strategies. Nature 319: 675-678.
13. Keating, M.R., Wilhelm, M.P., and Walker, R.C. 1992. Strategies for prevention of infection after cardiac transplantation. [Review] [65 refs]. Mayo Clin. Proc. 67: 676-684.
14. + T cell immunity against fatal Toxoplasma gondii infection in mice. J. Immunol. 147: 3501-3506.
15. Ljunggren, H.G., Stam, N.J., Öhlen, C., Neefjes, J.J., Höglund, P., Heemels, M.T., Bastin, J., Schumacher, T.N., Townsend, A., Kärre, K., and Ploegh, H.L. 1990. Empty MHC class I molecules come out in the cold. Nature 346: 476-480.
16. Low, M.G., and Saltiel, A.R. 1988. Structural and functional roles of glycosyl-phosphatidylinositol in membranes. [Review] [104 refs]. Science 239: 268-275.
17. Luft, B.J., and Remington, J.S. 1992. Toxoplasmic encephalitis in AIDS. [Review] [138 refs]. Clin. Infect. Dis. 15: 211-222.
18. Michaels, M.G., Wald, E.R., Fricker, F.J., Del Nido, P.J., and Armitage, J. 1992. Toxoplasmosis in pediatric recipients of heart transplants. [Review] [26 refs]. Clin. Infect. Dis. 14: 847-851.
19. Öhlen, C., Bastin, J., Ljunggren, H.G., Foster, L., Wolpert, E., Klein, G., Townsend, A.R.M., and Kärre, K. 1990. Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant. J. Immunol. 145: 52-58.
20. Remington, J.S., McLeod, R., and Desmonts, G. 1995. Toxoplasmosis, p. 140-267. In Remington, J.S., and Klein, J.O. (eds), Infectious diseases of the fetus and newborn infant, 4th ed, W.B. Saunders Co., Philadelphia, U.S.A.
21. Renold, C., Sugar, A., Chave, J.P., Perrin, L., Delavelle, J., Pizzolato, G., Burkhard, P., Gabriel, V., and Hirschel, B. 1992. Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine 71: 224-239.
22. Rock, K.L., Rothstein, L., and Benacerraf, B. 1992. Analysis of the association of peptides of optimal length to class I molecules on the surface of cells. Proc. Natl. Acad. Sci. U.S.A. 89: 8918-8922.
23. Salt, A., Sutehall, G., Sargaison, M., Woodward, C., Barnes, N.D., Calne, R.Y., and Wreghitt, T.G. 1990. Viral and Toxoplasma gondii infections in children after liver transplantation. J. Clin. Pathol. 43: 63-67.
24. + T cells in mice. J. Immunol. 140: 3943-3946.
25. Townsend, A., Öhlen, C., Bastin, J., Ljunggren, H.G., Foster, L., and Kärre, K. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340: 443-448.
26. Townsend, A., Öhlen, C., Foster, L., Bastin, J., Ljunggren, H.G., and Kärre, K. 1989. A mutant cell in which association of class I heavy and light chains is induced by viral peptides. Cold Spring Harbor Symp. Quant. Biol. 1: 299-308.
27. Waldeland, H., and Frenkel, J.K. 1983. Live and killed vaccines against toxoplasmosis in mice. J. Parasitol. 69: 60-65.
28. Yamakawa, R., Yamashita, Y., Yano, A., Morita, J., and Kata, H. 1996. Congenital toxoplasmosis complicated by central diabetes insupidus in an infant with Down syndrome. Brain Dev. 18: 75-77.
29. + cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells. J. Immunol. 154: 290-298.
30. + cytotoxic cells. J. Parasitol. 75: 411-416.
31. Yano, A., Ohno, S., Norose, K., Baba, T., Yamashita, K., Aosai, F., and Segawa, K. 1992. Antigen presentation by Toxoplasma-infected cells: antigen entry through cell membrane fusion. Int. Arch. Allergy Immunol. 98: 13-17.
32. Yano, A., Aosai, F., Yang, T.H., He, N., Mun, H.S., Liu, H., Inoko, H., and Norose, K. 1997. Correlation between direct binding ability of synthetic T. gondii SAG1 peptides to HLA-A2 measured by a sensor for surface plasmon resonance and antigenicity of the peptides for T. gondii-infected cell-specific CTL. Biochem. Biophys. Res. Commun. 236: 257-261.